Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer

Journal of Urology

Volumn 170, Issue 2 I, 2003, Pages 428-432

  Marti, A ^a   Jichlinski, P ^a   Lange, N ^c   Ballini, J P ^c   Guillou, L ^b   Leisinger, H J ^a   Kucera, P ^d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^c Federal Institute of Technology   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Aminolevulinic acid; Protoporphyrins, bladder neoplasms, photosensitivity disorders, photochemotherapy

Indexed keywords

AMINOLEVULINIC ACID; HEXYL ESTER AMINOLEVULINATE; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; BLADDER MUSCLE; CHORION; CLINICAL ARTICLE; CLINICAL TRIAL; CONNECTIVE TISSUE; DRUG DISTRIBUTION; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT CANCER; SIDE EFFECT; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

EID: 0037477401     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000075054.38441.2d     Document Type: Article

References (20)

1. Kennedy, J. C. and Pottier, R. H.: Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B, 14: 275, 1992
2. Gaullier, J. M., Berg, K., Peng, Q., Anholt, H., Selbo, P. K., Ma, L. W. et al: Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res, 57: 1481, 1997
3. Marti, A., Lange, N., van den Bergh, H., Sedmera, D., Jichlinski, P. and Kucera, P.: Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol, 162: 546, 1999
4. Kriegmair, M., Baumgartner, R., Knüchel, R., Stepp, H., Hofstädter, F. and Hofstetter, A.: Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol, 155: 105, 1996
5. Lange, N., Jichlinski, P., Zellweger, M., Forrer, M., Marti, A., Guillou, L. et al: Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer, 80: 185, 1999
6. Mostofino, F. K., Sobin, L. H. and Torloni, H.: Histological typing of urinary bladder tumors. In: International Histological Classification of Tumors. Geneva: World Health Organization, 1973
7. Hermanek, P. and Sobin, J.: UICC TNM Classification of Malignant Tumors, 4th ed. Berlin: Springer Verlag, 1992
8. D'Hallewin, M. A. and Baert, L.: Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. Urology, 45: 763, 1995
9. Harty, J. I., Amin, M., Wieman, T. J., Tseng, M. T., Ackerman, D. and Broghamer, W.: Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J Urol, 141: 1341, 1989
10. Jichlinski, P. and Leisinger, H. J.: Photodynamic therapy in superficial bladder cancer: past, present and future. Urol Res, 29: 396, 2001
11. Xiao, Z., Miller, G. G., McCallum, T. J., Brown, K. M., Lown, J. W., Tulip, J. et al: Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy. Photochem Photobiol, 67: 573, 1998
12. Grönlund-Pakkanen, S., Wahlfors, J., Mäkinen, K., Pakkanen, T. M., Talja, M., Ala-Opas, M. et al: The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma. J Urol, 167: 1848, 2002
13. Chang, S.-C., MacRobert, A. J. and Bown, S. G.: Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid. J Urol, 155: 1744, 1996
14. Chang, S.-C., MacRobert, A. J. and Bown, S. G.: Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes. J Urol, 155: 1749, 1996
15. Datta, S. N., Loh, C. S., MacRobert, A. J., Whatley, S. D. and Matthews, P. N.: Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. Br J Cancer, 78: 1113, 1998
16. Steinbach, P., Kriegmair, M., Baumgartner, R., Hofstadter, F. and Knuchel, R.: Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. Urology, 44: 676, 1994
17. Kriegmair, M., Baumgartner, R., Lumper, W., Waidelich, R. and Hofstetter, A.: Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol, 77: 667, 1996
18. Van Staveren, H. J., Beek, J. F., Verlaan, C. W., Edixhoven, A., De Reijke, T. M., Brutel De La RiviEre, G. et al: Comparison of normal piglet bladder damage after PDT with oral or intravesical administration of ALA. Lasers Med Sci, 17: 238, 2002
19. Jichlinski, P., Marti, A., Aymon, D., Lange, N., Wagnieres, G., Guillou, L. et al: First experience of hexyl-ester aminolevulinic acid induced fluorescence cystoscopy in patients with superficial bladder cancer. J Urol, suppl., 167: 160, abstract 644, 2002
20. Rick, K., Sroka, R., Stepp, H., Kriegmair, M., Huber, R. M., Jacob, K. et al: Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B, 40: 313, 1997